Aspen Pharmacare (OTCMKTS:APNHY) Hits New 12-Month High – Time to Buy?
by Sarita Garza · The Markets DailyShares of Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $9.2240 and last traded at $9.2240, with a volume of 431 shares trading hands. The stock had previously closed at $8.77.
Aspen Pharmacare Trading Up 5.2%
The company has a fifty day moving average price of $8.47 and a two-hundred day moving average price of $7.59. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.